StockWatch
·

ITD CEMENTATION INDIA LTD.

BSE: 509496

P/L Snapshot

Q1 FY27 · standalone

vs Q4 FY26·vs Q1 FY26
Revenue
2.7K
-11.2%+4.0%
Expenditure
2.5K
-6.6%+3.3%
Net Profit
137.55
-42.5%+0.2%
OPM %
10.18%
-1.99pp+0.70pp

Shareholding

Pattern breakdown

P/L Trends

(in crores)

RevenueExpenditureNet Profit
0.00839.721.7K2.5K3.4KQ2 FY27Q2 FY25Q3 FY25Q4 FY25Q1 FY26Q2 FY26Q3 FY26Q4 FY26Q1 FY27
Price Chart
Reports

Metro & Port Ramp Awaits: Q2 Is the Pivot for FY27 Guidance

infrastructure · order book · metro projects

Result previewQ2 FY2705 Nov 20263 minIndustrials & Infra

Order Tripled, Revenue Stalled—Execution Risk Now Defines the Read

order acceleration · execution delays · metro ramp

Result verdictFollow-upQ1 FY2717 Aug 20266 minIndustrials & Infra

Strong order pipeline masks weak quarterly start; margin holding amid cost pressures

order acceleration · execution delays · margin defense

TranscriptDeep diveQ1 FY2717 Aug 20266 minIndustrials & Infra
Latest
Quarterly Result6h ago

Cemindia: consolidated PAT +21% YoY to ₹131 Cr on 25% revenue growth, margin dips to 10.2%

Cemindia Projects (formerly ITD Cementation India, now under Renew Exim/Adani-group promoter) reported consolidated revenue of ₹2,748.65 Cr for Q2 FY27, up 25.2% YoY from ₹2,195.21 Cr and roughly flat (+1.0%) QoQ against ₹2,720.92 Cr. Consolidated PAT grew 21.3% YoY to ₹130.59 Cr (standalone PAT ₹127.57 Cr, EPS ₹7.43 standalone / ₹7.60 consolidated) but fell 7.3% QoQ from ₹140.83 Cr. No analyst consensus estimates specific to this quarter turned up in a web search, so vsStreet is marked unknown rather than guessed. Profitability growth trailed topline growth because EBITDA margin slipped to 10.2% from 11.1% a year earlier (NPM also eased to roughly 4.7% from 4.8%), as cost of construction materials and subcontracting/other direct costs scaled with execution volumes. That margin still sits above the "10%+ sustainable" floor management reiterated on the August 2026 concall, so guidance is met on that specific metric even as the year-on-year give-back bears watching. Neither the current nor the year-ago quarter carried exceptional items, so the growth rates above are already on a clean, comparable basis — no adjustment is needed. The quarter's other corporate actions reinforce a balance-sheet-strengthening story: the order book rose to a record ₹32,715 Cr after ₹3,485 Cr of fresh Q2 wins, taking H1 FY27 inflow to ₹12,005 Cr — about 48% of the ₹25,000 Cr annual order-inflow target set out at the Q1 call. The company also raised ₹1,400 Cr via QIP in October 2026 at ₹1,108/share, bringing net debt to ₹773 Cr and net debt-to-equity to 0.30x; ICRA and CARE upgraded their long-term ratings to AA and AA- respectively, and Crisil assigned a fresh AA rating. MD Jayanta Basu's press statement called it "another quarter of consistent operational and financial performance," a framing the topline and order-book numbers support, though it does not address the EBITDA margin dip. H1 FY27 revenue growth of just 14.6% YoY (₹5,470 Cr vs ₹4,772 Cr) is running well below the reaffirmed 25% full-year revenue growth target, so H2 execution needs to step up materially — against a record order book that at least provides the visibility to do so — for the annual guidance to hold.

5 Nov 2026, 02:33 pm

Corporate Events

Board MeetingCEMPRO
2026
5Nov

Board Meeting

The meeting of the Board of Directors of the Company will be…

BSE Filing ↗
Board MeetingCEMPRO
2026
14Oct

Board Meeting

The Management Committee considered and approved the opening…

BSE Filing ↗
Board MeetingCEMPRO
2026
17Aug

Board Meeting

To consider and approve raising capital from eligible invest…

BSE Filing ↗
Board MeetingCEMPRO
2026
28Jul

Board Meeting

The meeting of the Board of Directors will be held to consid…

BSE Filing ↗
Board MeetingCEMPRO
2026
23Jul

Board Meeting

The Board of Directors meeting is scheduled to consider and …

BSE Filing ↗
Board MeetingCEMPRO
2026
27Jun

Board Meeting

The 48th Annual General Meeting of the Company will be held …

BSE Filing ↗
Board MeetingCEMPRO
2026
29Apr

Board Meeting

To consider and approve audited financial results for the qu…

BSE Filing ↗
Board MeetingCEMPRO
2025
5Nov

Board Meeting

Resignation of Statutory Auditor of the Company, Appointment…

BSE Filing ↗
Board MeetingCEMPRO
2024
7Nov

Board Meeting

Consider and approve

BSE Filing ↗
Board MeetingCEMPRO
2024
28May

Board Meeting

Consideration and approval of Audited Financial Results for …

BSE Filing ↗
Board MeetingCEMPRO
2024
8Feb

Board Meeting

Consider and approve Unaudited Financial Results for the qua…

BSE Filing ↗
Board MeetingCEMPRO
2023
8Nov

Board Meeting

Consider and approve Unaudited Financial Results

BSE Filing ↗